Pharmaron at Discovery & Development Europe 2025
Capabilities
Pharmaron was proud to participate in Discovery & Development Europe 2025, held from June 23rd to 24th at the Congress Centre Basel, Switzerland. Hosted by Oxford Global, this premier event brought together over 1,000 leaders from the pharmaceutical, biotechnology, and academic sectors. With a vibrant lineup of presentations and networking sessions, it provides an excellent platform for scientific collaboration.
About Discovery & Development Europe 2025
Discovery & Development Europe is a cornerstone for the life sciences community, where the latest developments in drug discovery and preclinical development can be discussed with colleagues and peers. The event fosters meaningful connections and knowledge sharing across disciplines, helping to accelerate innovation.
Pharmaron at Discovery & Development Europe 2025
Pharmaron attended with a strong multidisciplinary team, including Fabio Spreafico, Anna Witkowska, Jens-Peter Muller, and Giulia Miserocchi. The team presented the poster “in vivo CRISPR Screening,” highlighting how in vivo screening enables the study of biological processes where their natural niche and physiological conditions influence cells.
Additionally, Dr. Elnaz Gozalpour delivered a compelling presentation titled “Caco2: an overlooked cell line in the prediction of CNS penetration.”, highlighting Pharmaron’s capabilities in CNS penetration.
“Our team greatly enjoyed Discovery and Development as an opportunity to connect with customers and have interesting conversations,”
said Fabio Spreafico,
Associate Director of Business Development.
Pharmaron’s successful participation at Discovery & Development Europe 2025 reinforces its commitment to advancing science through collaboration and innovative research. We look forward to continuing the conversations sparked in Basel!